Wall Street strategists recommend stable dividend-paying investments

Wall Street strategists recommend stable dividend-paying investments

Traders work the floor of the New York Stock Exchange on August 23, 2019 in New York. Don Emmert | AFP | Getty Images Stocks may be at record highs, but 2020 has already proven to be a volatile year, leading a growing cohort of Wall Street strategists to recommend stable dividend-paying investments. Favorite names … Read more…

Iran retaliation, Ford sales and service sector data

GrubHub, Boeing, Amazon, WD-40 & more

Check out the companies making headlines before the bell: GrubHub (GRUB) – GrubHub denied a Wall Street Journal report that it was mulling options that included a possible sale. In a statement to CNBC, the food delivery service said there was “unequivocally no process in place to sell the company and there are currently no … Read more…

Migraine sufferers have new tool with approval of Allergan's Ubrelvy

Migraine sufferers have new tool with approval of Allergan’s Ubrelvy

A doctor draws Allergan’s Botox into a syringe before administering it to a patient at the offices of Marcus Facial Plastic Surgery in Redondo Beach, California. Patrick T. Fallon | Bloomberg | Getty Images Migraine sufferers have a new tool in their arsenal to fight the debilitating headaches with federal approval of Allergan’s first oral … Read more…

Mnuchin's USMCA growth estimate might be too optimistic

Mnuchin’s USMCA growth estimate might be too optimistic

A commercial truck exits the highway for the Bridge to Canada, in Detroit, Michigan, August 30, 2018. Rebecca Cook | Reuters U.S. Treasury Secretary Steven Mnuchin says the replacement for the North American Free Trade Agreement will boost the U.S. economy by .5%, but some leading economists do not agree. “I think we are going … Read more…

Warren claims Eli Lilly failed on cheaper insulin. CEO says 'nonsense'

Warren claims Eli Lilly failed on cheaper insulin. CEO says ‘nonsense’

Eli Lilly CEO David Ricks said Tuesday that Sen. Elizabeth Warren’s accusation that the drugmaker failed on its pledge to provide patients with lower-priced insulin is “nonsense.” Warren, among the frontrunners in the 2020 presidential race, released a survey Monday, which looked at 190 chains and 196 independent pharmacies across all 50 states. The results … Read more…

What happened to stock market Monday: Tech rises to records

What happened to stock market Monday: Tech rises to records

Traders and financial professionals work on the floor of the New York Stock Exchange (NYSE) ahead of the closing bell, June 21, 2019 in New York City. Drew Angerer | Getty Images Dow Jones Industrial Average rises 100 points The Dow gained 100.51 points, or 0.36% to end the day at 28,235.89. The S&P 500 … Read more…

FedEx earnings, economic data, Eli Lilly outlook

FedEx earnings, economic data, Eli Lilly outlook

Here are the most important things to know about Tuesday before you hit the door. 1. FedEx earnings Shipping company FedEx reports fiscal second quarter earnings after the bell on Tuesday. Wells Fargo is forecasting earnings per share of $2.83 on revenue of $17.76 billion. In the same quarter last year, FedEx reported earnings of … Read more…

Lighthizer acknowledges USMCA concessions: 'Democrats won the House'

Lighthizer acknowledges USMCA concessions: ‘Democrats won the House’

U.S. Trade Representative Robert Lighthizer acknowledged on Sunday the White House had to make concessions in order to sign its USMCA trade agreement. “We had an election and the Democrats won the House,” he said, when CBS’ Margaret Brennan asked about wins the Democrats were claiming in their negotiation of the bill. “It was always … Read more…

Biogen's stock rises 4% after releasing new data on late-stage Alzheimer's drug

Biogen’s stock rises 4% after releasing new data on late-stage Alzheimer’s drug

The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019. John Tlumacki | Boston Globe | Getty Images Biogen shares rose Thursday after the biotech firm offered more data on its late-stage Alzheimer’s drug, aducanumab. The data, presented at the Clinical Trials on Alzheimer’s Disease conference, offered … Read more…

UBS dividend stocks to combat a slowing economy, tougher market

UBS dividend stocks to combat a slowing economy, tougher market

A trader, center, wears a Citigroup jacket while working on the floor of the New York Stock Exchange. Michael Nagle | Bloomberg | Getty Images U.S. stock markets are near record high levels and UBS strategists are predicting a continued slowdown in the economy, which the firm expects will pressure the S&P 500 until the … Read more…